ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA
· Real-Time Price · USD
4.57
-0.25 (-5.28%)
At close: Aug 19, 2025, 3:59 PM
4.62
1.09%
Pre-market: Aug 20, 2025, 08:07 AM EDT
ENDRA Life Sciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 211.6K | 211.6K | 211.6K | 428.41K | 428.41K | 428.41K | 428.41K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 184.17K | 201.51K | 211.6K | 167.05K | 237.5K | 260.08K | 275.45K | 281.97K | 270.12K | 253.08K | 234.26K | 220.16K | 223.07K | 227.76K | 224.41K | 170.75K | 109.24K | 48.87K |
Gross Profit | 27.43K | 10.09K | n/a | 261.36K | 190.91K | 168.32K | 152.96K | -281.97K | -270.12K | -253.08K | -234.26K | -220.16K | -223.07K | -227.76K | -224.41K | -170.75K | -109.24K | -48.87K |
Operating Income | -8.58M | -9.51M | -10.82M | -7.98M | -9.6M | -10.36M | -10.52M | -12.38M | -12.66M | -13.24M | -13.16M | -12.92M | -12.15M | -11.78M | -11.5M | -10.68M | -11.29M | -10.98M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -8.77M | -9.77M | -11.51M | -8.82M | -9.57M | -9.89M | -10.06M | -11.89M | -12.23M | -13.26M | -13.18M | -12.99M | -12.21M | -11.82M | -11.23M | -10.38M | -10.98M | -10.67M |
Net Income | -8.77M | -9.77M | -11.51M | -8.82M | -9.57M | -9.89M | -10.06M | -11.87M | -12.23M | -13.29M | -2,858.2B | -2,858.2B | -2,858.2B | -2,858.2B | -11.23M | -10.38M | -10.98M | -10.67M |
Selling & General & Admin | 6.23M | 6.83M | 7.63M | 4.85M | 5.63M | 5.71M | 5.52M | 6.29M | 6.38M | 6.51M | 6.6M | 6.6M | 6.49M | 6.22M | 6.02M | 5.48M | 5.49M | 5.44M |
Research & Development | 2.34M | 2.68M | 3.19M | 3.13M | 3.97M | 4.65M | 5M | 6.09M | 6.29M | 6.73M | 6.55M | 6.31M | 5.66M | 5.55M | 5.48M | 5.2M | 5.8M | 5.54M |
Other Expenses | n/a | n/a | 4.84K | 3.08K | 31.31K | 468.74K | 460.49K | 486.03K | 434.79K | -22.02K | -21.53K | -78.41K | -62.9K | -42.44K | -41.55K | -4.88K | 9.00 | 188.00 |
Operating Expenses | 8.58M | 9.51M | 10.76M | 7.86M | 9.48M | 10.25M | 10.46M | 12.38M | 12.66M | 13.24M | 13.16M | 12.92M | 12.15M | 11.78M | 11.5M | 10.68M | 11.29M | 10.98M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 3.42K | 3.42K | 26.43K | 45.8K | 2,858.2B | 2,858.2B | 2,858.2B | 2,858.2B | n/a | n/a | n/a | 3.86K |
Selling & Marketing Expenses | 307.25K | 401.37K | 571.04K | 632.6K | 792.78K | 877.6K | 820.55K | 999.49K | 1.18M | 1.27M | 1.43M | 1.48M | 1.34M | 1.25M | 1.08M | 885.69K | 749.87K | 627.87K |
Cost & Expenses | 8.74M | 9.67M | 10.98M | 7.98M | 9.6M | 10.36M | 10.52M | 12.38M | 12.66M | 13.24M | 13.16M | 12.92M | 12.15M | 11.78M | 11.5M | 10.68M | 11.29M | 10.98M |
Income Tax Expense | n/a | n/a | 4.00 | 7.00 | 7.00 | 7.00 | 3.42K | -20.37K | 2.64K | 22.02K | 2,858.2B | 2,858.2B | 2,858.2B | 2,858.2B | -6.42K | -2.84K | 4.67K | 8.7K |
Shares Outstanding (Basic) | 717.11K | 557.58K | 536.91K | 1.12M | 1.71M | 1.71M | 1.71M | 1.71M | 1.71M | 1.93M | 1.93M | 1.93M | 1.93M | 2.15M | 2.1M | 2.1M | 2.08M | 1.89M |
Shares Outstanding (Diluted) | 717.11K | 557.58K | 536.91K | 1.12M | 1.71M | 1.71M | 1.71M | 1.71M | 1.71M | 1.93M | 1.93M | 1.93M | 1.93M | 2.15M | 2.1M | 2.1M | 2.08M | 1.89M |
EPS (Basic) | -13.4 | -13 | -12.77 | -5.89 | -5.61 | -5.8 | -5.7 | -6.54 | -6.51 | -6.88 | -1.33M | -1.33M | -1.33M | -1.33M | -5.49 | -5.89 | -7.35 | -9.74 |
EPS (Diluted) | -13.4 | -13 | -12.77 | -5.89 | -5.61 | -5.8 | -5.7 | -6.54 | -6.51 | -6.88 | -1.33M | -1.33M | -1.33M | -1.33M | -5.49 | -5.89 | -7.35 | -9.74 |
EBITDA | -8.01M | -8.92M | -10.65M | -7.79M | -9.33M | -10.11M | -10.26M | -12.08M | -12.43M | -13.01M | -12.94M | -12.77M | -11.99M | -11.59M | -11.33M | -10.48M | -11.14M | -10.85M |
EBIT | -8M | -8.93M | -10.67M | -7.98M | -9.6M | -10.36M | -10.52M | -12.38M | -12.66M | -13.24M | -13.16M | -12.95M | -12.18M | -11.81M | -11.53M | -10.68M | -11.28M | -10.97M |
Depreciation & Amortization | 178.75K | 196.08K | 206.17K | 221.06K | 237.5K | 260.08K | 275.45K | 281.97K | 270.12K | 253.08K | 234.26K | 220.16K | 223.07K | 227.76K | 224.41K | 242.02K | 198.28K | 176.62K |